Sign inGet started

Saluri Joseph

Insider CIK 1512131 · NLNK Director · KMPH Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2023-04-252023-05-0839,200— $039,200SEC↗
KMPH KEMPHARM, INC A Award deriv2022-06-282022-06-3015,000— $015,000SEC↗
KMPH KEMPHARM, INC A Award deriv2021-06-172021-06-2115,000— $015,000SEC↗
KMPH KEMPHARM, INC A Award deriv2020-06-192020-06-2230,000— $030,000SEC↗
KMPH KEMPHARM, INC A Award2019-06-302019-07-027,857— $020,899SEC↗
KMPH KEMPHARM, INC A Award2019-05-102019-05-148,487— $013,042SEC↗
KMPH KEMPHARM, INC A Award deriv2019-04-242019-04-2630,000— $030,000SEC↗
KMPH KEMPHARM, INC A Award deriv2018-05-222018-05-2415,000— $015,000SEC↗
KMPH KEMPHARM, INC A Award deriv2017-05-232017-05-2410,000— $010,000SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2017-05-122017-05-1613,309— $013,309SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2016-08-092016-08-1117,773— $017,773SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2016-08-092016-08-114,783— $04,783SEC↗
KMPH KEMPHARM, INC A Award deriv2016-05-242016-05-2610,000— $010,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-08-252015-08-2710,000— $010,000SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise deriv2015-07-132015-07-152,500— $09,404SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise deriv2015-07-132015-07-152,500— $09,402SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise2015-07-132015-07-152,500$13.30 $33.3K18,548SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise2015-07-132015-07-152,500$3.07 $7.7K21,048SEC↗
(NLNK) NEWLINK GENETICS CORP S Sale2015-07-132015-07-155,000$50.42 $252.1K16,048SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2015-04-302015-07-176,349— $06,349SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2015-04-302015-05-043,643— $03,643SEC↗
(NLNK) NEWLINK GENETICS CORP A Award2015-04-302015-05-041,962— $016,048SEC↗
KMPH KEMPHARM, INC C Conversion deriv2015-04-212015-04-2116,130— $00SEC↗
KMPH KEMPHARM, INC C Conversion deriv2015-04-212015-04-2118,044— $00SEC↗
KMPH KEMPHARM, INC C Conversion2015-04-212015-04-214,555— $04,555SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2014-05-012015-07-1715,659— $015,659SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2014-05-012014-05-058,831— $08,831SEC↗
(NLNK) NEWLINK GENETICS CORP A Award2014-05-012014-05-052,944— $014,086SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise deriv2014-02-072014-02-114,761— $00SEC↗
(NLNK) NEWLINK GENETICS CORP M Exercise2014-02-072014-02-114,761$3.07 $14.6K15,903SEC↗
(NLNK) NEWLINK GENETICS CORP S Sale2014-02-072014-02-114,761$38.80 $184.7K11,142SEC↗
(NLNK) NEWLINK GENETICS CORP A Award2014-01-022014-01-063,000— $011,142SEC↗
(NLNK) NEWLINK GENETICS CORP A Award deriv2013-05-092013-05-1012,000— $012,000SEC↗
NLNK NEWLINK GENETICS CORP A Award deriv2012-11-022012-11-0611,902— $011,902SEC↗